m40 has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawley, JN; McDonald, MP; Wenk, GL | 1 |
| Crawley, JN; McDonald, MP; Wenk, GL; Willard, LB | 1 |
2 other study(ies) available for m40 and Alzheimer Disease
| Article | Year |
|---|---|
Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin.
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal; Brain Mapping; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Galanin; Hippocampus; Immunotoxins; Male; Mental Recall; N-Glycosyl Hydrolases; Orientation; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Galanin; Receptors, Gastrointestinal Hormone; Ribosome Inactivating Proteins, Type 1; Saporins | 1997 |
Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.
Topics: Acetylcholine; Alzheimer Disease; Animals; Antibodies, Monoclonal; Behavior, Animal; Choice Behavior; Cholinergic Agents; Cholinergic Fibers; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Galanin; Immunotoxins; Male; Memory; Muscarinic Agonists; N-Glycosyl Hydrolases; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Ribosome Inactivating Proteins, Type 1; Saporins; Thiadiazoles | 1998 |